Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000895345-24-000595
Filing Date
2024-11-19
Accepted
2024-11-19 21:31:34
Documents
3
Group Members
AARON I. DAVISBOXER CAPITAL MANAGEMENT, LLCMVA INVESTORS, LLC

Document Format Files

Seq Description Document Type Size
1 ff4142386_13da5-tyra.htm SC 13D/A 196025
2 ff4142386_ex7-tyra.htm EX-7 47761
3 ff4142386_ex8-tyra.htm EX-8 49774
  Complete submission text file 0000895345-24-000595.txt   295232
Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Subject) CIK: 0001863127 (see all company filings)

EIN.: 831476348 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92865 | Film No.: 241478022
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 12860 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12860 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 8584003115
Boxer Capital Management, LLC (Filed by) CIK: 0002018299 (see all company filings)

EIN.: 990921494 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A